[CADL] YoY Quarter Result on 30-Jun-2020 [#Q2]

Stock
[CADL] Candel Therapeutics, Inc.
Announcement Date
29-Jun-2020
Financial Year
2020
Quarter
30-Jun-2020 [#Q2]
Profit Trend
QoQ- -62.30%
YoY-
Quarter Report
CADL's Result
CADL's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 CAGR
Revenue 0 0 31 31 31 -
PBT -22,237 -9,614 -4,149 -17,080 -2,876 66.69%
Tax 0 644 -4,604 15 413 -
NP -22,237 -9,614 455 -17,080 -2,876 66.69%
Tax Rate - - - - - -
Total Cost 22,237 9,614 -424 17,111 2,907 66.24%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 CAGR
NP Margin 0.00 0.00 1,467.74 -55,096.77 -9,277.42 -
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 CAGR
EPS -0.74 -0.33 0.02 -0.69 -0.15 48.99%
EPS Diluted -0.74 -0.33 0.02 -0.69 -0.15 48.99%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.